Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease

Clinical trial NCT05424926 · COMPLETED

Trial details

NCT number: NCT05424926
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Study type: OBSERVATIONAL

Rheumatoid Arthritis Spondyloarthritis Psoriatic Arthritis

Start date: 2023-02-24
Primary completion: 2023-12-14
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.